+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Ebola virus Infections (Ebola Hemorrhagic Fever) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4768277
  • Report
  • April 2019
  • Region: Global
  • 75 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Arbutus Biopharma Corp
  • Bavarian Nordic A/S
  • Chimerix Inc
  • Gilead Sciences Inc
  • GlaxoSmithKline Plc
  • ICON Plc
  • MORE
The global clinical trial report- “2019 Ebola virus Infections (Ebola Hemorrhagic Fever) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Ebola virus Infections (Ebola Hemorrhagic Fever). It presents in-depth analysis of Ebola virus Infections (Ebola Hemorrhagic Fever) clinical trials across markets and companies. The research work is for providing complete understanding into trends in Ebola virus Infections (Ebola Hemorrhagic Fever).

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Ebola virus Infections (Ebola Hemorrhagic Fever) clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Ebola virus Infections (Ebola Hemorrhagic Fever)

The research work is prepared through extensive and continuous research on Ebola virus Infections (Ebola Hemorrhagic Fever) trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Ebola virus Infections (Ebola Hemorrhagic Fever) patients are identified
  • The report includes panorama of Ebola virus Infections (Ebola Hemorrhagic Fever) clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Ebola virus Infections (Ebola Hemorrhagic Fever) clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Arbutus Biopharma Corp
  • Bavarian Nordic A/S
  • Chimerix Inc
  • Gilead Sciences Inc
  • GlaxoSmithKline Plc
  • ICON Plc
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Ebola virus Infections (Ebola Hemorrhagic Fever) Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Ebola virus Infections (Ebola Hemorrhagic Fever) Clinical Trials by Region
2.2.2 Average Enrollment of Ebola virus Infections (Ebola Hemorrhagic Fever) Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Ebola virus Infections (Ebola Hemorrhagic Fever) Treatment, 2019

3. Region wise Ebola virus Infections (Ebola Hemorrhagic Fever) Clinical Trials
3.1 Asia Pacific Ebola virus Infections (Ebola Hemorrhagic Fever) Clinical Trials by Country
3.2 Europe Ebola virus Infections (Ebola Hemorrhagic Fever) Clinical Trials by Country
3.3 North America Ebola virus Infections (Ebola Hemorrhagic Fever) Clinical Trials by Country
3.4 Middle East and Africa Ebola virus Infections (Ebola Hemorrhagic Fever) Clinical Trials by Country
3.5 South and Central America Ebola virus Infections (Ebola Hemorrhagic Fever) Clinical Trials by Country

4. Ebola virus Infections (Ebola Hemorrhagic Fever) Clinical Trial Trends
4.1 Start Year wise Ebola virus Infections (Ebola Hemorrhagic Fever) Clinical Trials
4.2 Phase wise Ebola virus Infections (Ebola Hemorrhagic Fever) Clinical Trials
4.3 Trial Status wise Ebola virus Infections (Ebola Hemorrhagic Fever) Clinical Trials
4.4 Trial Type wise Ebola virus Infections (Ebola Hemorrhagic Fever) Clinical Trials

5. Ebola virus Infections (Ebola Hemorrhagic Fever) Average Enrollment Trends
5.1 Average Enrollment in Ebola virus Infections (Ebola Hemorrhagic Fever) Trials by Year
5.2 Average Enrollment in Ebola virus Infections (Ebola Hemorrhagic Fever) Trials by Phase
5.3 Average Enrollment in Ebola virus Infections (Ebola Hemorrhagic Fever) Trials by Status
5.4 Average Enrollment in Ebola virus Infections (Ebola Hemorrhagic Fever) Trials by Type of Trial

6. Companies Participating in Ebola virus Infections (Ebola Hemorrhagic Fever) Clinical Trials
6.1 Ebola virus Infections (Ebola Hemorrhagic Fever) Trials by Sponsor Type
6.2 Ebola virus Infections (Ebola Hemorrhagic Fever) Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Ebola virus Infections (Ebola Hemorrhagic Fever) Trials- Phase 1
7.2 Ebola virus Infections (Ebola Hemorrhagic Fever) Trials- Phase 2
7.3 Ebola virus Infections (Ebola Hemorrhagic Fever) Trials- Phase 3
7.4 Ebola virus Infections (Ebola Hemorrhagic Fever) Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Ebola virus Infections (Ebola Hemorrhagic Fever) Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Ebola virus Infections (Ebola Hemorrhagic Fever) Clinical Trials and Enrolment
Figure 5: Europe - Country wise Ebola virus Infections (Ebola Hemorrhagic Fever) Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Ebola virus Infections (Ebola Hemorrhagic Fever) Clinical Trials and Enrolment
Figure 7: North America - Country wise Ebola virus Infections (Ebola Hemorrhagic Fever) Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Ebola virus Infections (Ebola Hemorrhagic Fever) Clinical Trials and Enrolment
Figure 9: Ebola virus Infections (Ebola Hemorrhagic Fever) Clinical Trials by Phase
Figure 10: Ebola virus Infections (Ebola Hemorrhagic Fever) Clinical Trials by Trial Status
Figure 11: Ebola virus Infections (Ebola Hemorrhagic Fever) Clinical Trials by Type
Figure 12: Ebola virus Infections (Ebola Hemorrhagic Fever) Clinical Trials by Sponsor Type
Figure 13: Ebola virus Infections (Ebola Hemorrhagic Fever) Clinical Trials by Leading Sponsors
Figure 14: Ebola virus Infections (Ebola Hemorrhagic Fever) Average Enrollment by Phase
Figure 15: Ebola virus Infections (Ebola Hemorrhagic Fever) Average Enrollment by Trial Status
Figure 16: Ebola virus Infections (Ebola Hemorrhagic Fever) Average Enrollment by Type
Figure 17: Ebola virus Infections (Ebola Hemorrhagic Fever)- Average Enrolment by Type of Sponsors
Figure 18: Ebola virus Infections (Ebola Hemorrhagic Fever)- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Ebola virus Infections (Ebola Hemorrhagic Fever) Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Ebola virus Infections (Ebola Hemorrhagic Fever) Clinical Trials and Enrolment
Table 5: Europe - Country wise Ebola virus Infections (Ebola Hemorrhagic Fever) Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Ebola virus Infections (Ebola Hemorrhagic Fever) Clinical Trials and Enrolment
Table 7: North America - Country wise Ebola virus Infections (Ebola Hemorrhagic Fever) Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Ebola virus Infections (Ebola Hemorrhagic Fever) Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Ebola virus Infections (Ebola Hemorrhagic Fever) Average Enrollment by Phase
Table 15: Ebola virus Infections (Ebola Hemorrhagic Fever) Average Enrollment by Trial Status
Table 16: Ebola virus Infections (Ebola Hemorrhagic Fever) Average Enrollment by Type
Table 17: Ebola virus Infections (Ebola Hemorrhagic Fever)- Average Enrolment by Type of Sponsors
Table 18: Ebola virus Infections (Ebola Hemorrhagic Fever)- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Arbutus Biopharma Corp
  • Bavarian Nordic A/S
  • Chimerix Inc
  • Gilead Sciences Inc
  • GlaxoSmithKline Plc
  • ICON Plc
  • Johnson & Johnson
  • Merck & Co Inc
  • NewLink Genetics Corp
  • Tianjin CanSino Biotechnology Inc
Note: Product cover images may vary from those shown
Adroll
adroll